Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

NCT01434394 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT01434394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01434394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2011
Completion date
February 28, 2017
Enrollment
243 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effects of chemotherapy, locally advanced malignant neoplasm, oral cancer, oropharyngeal carcinoma